OLFM4 and neoplasm: Importantly, we found that inflammatory CAFs (iCAFs) enhance tumor stemness by upregulating SOX9 and OLFM4, contributing to drug resistance and cell proliferation through the AREG‐ERBB2 signaling pathway.